Texas Oncology is a clinical research site located in Fort Worth, Texas, United States 76104.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology has participated in 25 clinical trials with 4 currently active.
Therapeutic areas: Lymphoma, T-Cell, Peripheral, Ovarian Cancer, Endometrial Adenocarcinoma.
Sponsors: Eisai Inc., Unither Pharmaceuticals, Acrivon Therapeutics.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology has 25 clinical trials on record, with 4 currently active. Their work covers Lymphoma, T-Cell, Peripheral, Ovarian Cancer, Endometrial Adenocarcinoma.
Yes — Texas Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.